Chinese Journal of Pharmaceuticals
|
2023, 54(5): 791-796
• Pharmaceutical Management & Information •
Opinions on Regulatory Requirements and Pharmaceutical Research of Polymorphic Drugs
Full
Xiaohong XU, Fei LI, Liu YANG, Yongai SI, Qing GONG
*
Affiliations
- Center for Drug Evaluation, NMPA, Bejing 100022
Published: 2023-05-10
doi: 10.16522/j.cnki.cjph.2023.05.021
Outline
徐晓宏, 李飞, 杨柳, 司咏霭, 龚青.
多晶型药物的监管要求及其药学研究思考.
中国医药工业杂志,
2023
, 54
(5)
: 791
-796
.
DOI: 10.16522/j.cnki.cjph.2023.05.021
Xiaohong XU, Fei LI, Liu YANG, Yongai SI, Qing GONG.
Opinions on Regulatory Requirements and Pharmaceutical Research of Polymorphic Drugs[J].
Chinese Journal of Pharmaceuticals,
2023
, 54
(5)
: 791
-796
.
DOI: 10.16522/j.cnki.cjph.2023.05.021
Year 2023 volume 54 Issue 5
21
4
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2023.05.021
- Receive Date:2022-08-09
- Online Date:2026-11-19
- Published:2023-05-10